Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue



Status:Recruiting
Conditions:Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:5/26/2018
Start Date:January 2, 2018
End Date:June 2020
Contact:Stephanie M Munz, DDS
Email:smmunz@med.umich.edu
Phone:734 936-8289

Use our guide to learn which trials are right for you!

Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue (PGSRT): a Randomized Clinical Trial

This study will fill a scientific gap in the current knowledge providing data for evaluation
of the palatal augmentation prosthesis as a therapeutic modality in a robust scientific
randomized prospective clinical trial. Positive outcomes from this study have the potential
to dramatically alter the most common morbidity of oral cancer therapy, namely speech and
swallowing function in a population of patients with T1/T2 tumors of the tongue who are not
currently routinely recommended for a palatal augmentation prosthesis.


Inclusion Criteria:

- Patients with a new diagnosis of a T1/T2 tongue cancer

Exclusion Criteria:

- Patients with recurrent disease

- Patients with a history of prior head and neck radiation therapy

- Patients who lack adequate maxillary dentition to support a palatal augmentation
prosthesis
We found this trial at
1
site
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials